Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas
- PMID: 26212632
- PMCID: PMC4592470
- DOI: 10.1016/j.ypmed.2015.07.015
Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas
Abstract
Opioid addiction is no longer a primarily urban problem. As dependence on heroin and prescription pain relievers has become a significant issue in rural areas, the need for effective treatment of opioid-dependent pregnant women and their neonates has grown accordingly. In addition to the adverse perinatal outcomes associated with opioid addiction in pregnant women, the high costs of caring for these mothers and their babies motivate efforts to develop appropriate treatment models. We found that integration and coordination of services that promote maternal recovery and ability to parent are key requirements for treatment of opioid dependence during pregnancy. Unfortunately, lack of experience and resources makes such coordination a real challenge in rural areas. In this review, we discuss how we managed the challenges of developing a comprehensive program for treatment of opioid dependence during pregnancy. In addition, we outline our approach for facilitating the development of community-based programs to help these patients and families in rural regions of Vermont. Close relationships between our tertiary care center, local hospitals, community health care infrastructure, and legislators bolstered our efforts. In particular, appreciation for the severity and importance of the opioid-dependence problem in Vermont among health care providers and state legislators was paramount for our success in developing a state-wide treatment program. This approach can inform similar efforts in other rural regions of the United States, and has great potential to improve both access and quality of care for women struggling with opioid dependence.
Keywords: Buprenorphine; Methadone; Opioid dependence; Pregnancy; Rural.
Copyright © 2015. Published by Elsevier Inc.
Conflict of interest statement
Similar articles
-
Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.J Addict Med. 2012 Jun;6(2):124-30. doi: 10.1097/ADM.0b013e3182541933. J Addict Med. 2012. PMID: 22517450
-
Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.Prev Med. 2019 Nov;128:105786. doi: 10.1016/j.ypmed.2019.105786. Epub 2019 Jul 26. Prev Med. 2019. PMID: 31356827
-
Opioid use disorder during pregnancy in Tennessee: expediency vs. science.Am J Drug Alcohol Abuse. 2015;41(5):367-70. doi: 10.3109/00952990.2015.1047502. Am J Drug Alcohol Abuse. 2015. PMID: 26186388
-
Methadone and buprenorphine for the management of opioid dependence in pregnancy.Drugs. 2012 Apr 16;72(6):747-57. doi: 10.2165/11632820-000000000-00000. Drugs. 2012. PMID: 22512363 Review.
-
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.Pharmacotherapy. 2017 Jul;37(7):824-839. doi: 10.1002/phar.1958. Epub 2017 Jul 2. Pharmacotherapy. 2017. PMID: 28543191 Review.
Cited by
-
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.Addiction. 2018 Jul;113(7):1286-1294. doi: 10.1111/add.14192. Epub 2018 Mar 24. Addiction. 2018. PMID: 29443414 Free PMC article.
-
Severe Neonatal Opioid Withdrawal Requiring Pharmacotherapy: Impact of Region of Residence.Am J Perinatol. 2024 May;41(S 01):e654-e663. doi: 10.1055/a-1925-1659. Epub 2022 Aug 16. Am J Perinatol. 2024. PMID: 35973797 Free PMC article.
-
Neonatal abstinence syndrome.Nat Rev Dis Primers. 2018 Nov 22;4(1):47. doi: 10.1038/s41572-018-0045-0. Nat Rev Dis Primers. 2018. PMID: 30467370 Review.
-
Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.J Addict Med. 2017 May/Jun;11(3):178-190. doi: 10.1097/ADM.0000000000000308. J Addict Med. 2017. PMID: 28406856 Free PMC article. Review.
-
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study.J Subst Use Addict Treat. 2023 Jun;149:209030. doi: 10.1016/j.josat.2023.209030. Epub 2023 Apr 4. J Subst Use Addict Treat. 2023. PMID: 37023858 Free PMC article. Clinical Trial.
References
-
- American Association for the Treatment of Opioid Dependence. Increasing access to medication to treat opioid addiction-increasing access for the treatment of opioid addiction with medications. 2014 http://www.aatod.org/wpcontent/uploads/2014/07/MAT-Policy-Paper-FINAL-07.... Accessed 4-15-2015.
-
- Buckley V, Abdalvahed R, Haber P. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service. Aust NZ J Obstet Gynecol. 2013;53:464–70. - PubMed
-
- Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA psychiatry. 2014;71:821–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials